ALX Oncology Holdings Inc. (ALXO) Financials
ALXO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 242.6 million | 52.8 million |
2023-09-30 | 220.1 million | 51.4 million |
2023-06-30 | 245.9 million | 33.2 million |
2023-03-31 | 278.1 million | 37.8 million |
ALXO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -39.8 million | 6.7 million |
2023-09-30 | -29.9 million | 7.0 million |
2023-06-30 | -33.5 million | 6.2 million |
2023-03-31 | -28.5 million | 6.4 million |
ALXO Net Income
No data available :(
ALXO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 182.7 million | - | 7.6 million |
2023-09-30 | 196.4 million | - | - |
2023-06-30 | 212.8 million | - | - |
2023-03-31 | 227.9 million | 9.5 million | 956000 |
ALXO Shares Outstanding
ALXO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 148000 | 41.8 million | 6.2 million | 207000 |
2023-09-30 | 1.3 million | 45.8 million | 7.5 million | - |
2023-06-30 | 1.7 million | 29.5 million | 7.3 million | - |
2023-03-31 | 690000 | 24.8 million | 7.4 million | - |
ALXO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 207000 |
2023-09-30 | - | 209000 |
2023-06-30 | - | 513000 |
2023-03-31 | - | 518000 |
ALXO
Price: $16.98
52 week price:
Earnings Per Share: -3.74 USD
P/E Ratio: -4.38
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 63179
Market Capitalization: 613.4 million